Biocon Limited.
F&O₹399.95▼ -1.10 (-0.27%)
BIOCON·NSE·Healthcare
Market Cap
64993.34 Cr
PE Ratio
168.05
Volume
5,12,044
Day High - Low
402.40 - 397.90
52W High-Low
447.15 - 337.05
₹399.95▼ -1.10 (-0.27%)
Market Cap64993.34 Cr
PE Ratio168.05
Volume5,12,044
Day High - Low402.40 - 397.90
52W High-Low447.15 - 337.05
DocStoX Score
3.6/10
Poor
Fair Value
Sign in to see
ROE
1.40%
Weak
P/E
168.05x
Expensive
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
NIFTY 200NIFTY 500NIFTY MIDCAP 150
Day₹397.90
₹402.40
52W₹337.05
₹447.15
DocStoX take
Supported by risk (6.8) and momentum (6.0), but held back by valuation (0.0).
DocStoX score
Low confidence3.6
/10
Poor
Quality
Modest
ROE 1.4%
Valuation
Expensive
P/E 168.1×
Growth
Slow
Revenue +18.8% 5Y CAGR
Risk
Moderate
D/E 0.04
Momentum
Firm
57% of 52-week range
At a glance
Market Cap
₹64,993 Cr
52W High / Low
₹447 / ₹337
Dividend Yield
0.12%
Promoter Holding
44.68%
EPS (TTM)
₹2.38
Book Value
₹210.00
Key highlights
- Low leverage — D/E 0.04
- Profitable in all of the last 5 years
- Revenue compounding 19% a year
- Profit shrinking 15% a year
- Valuation is weak (0.0/10)
3 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore BIOCON LIMITED.’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
BIOCON LIMITED. peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value BIOCON LIMITED. with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing